Please enable Javascript

Labmeeting uses lots of Javascript - basically you can't use the site without it. So please enable Javascript in your browser. If your browser does not support Javascript, we recommend Firefox.

Papers authored by Lavielle G

Collect these papers and discover other ones on Labmeeting. Learn more.

S32006, a novel 5-HT(2C) receptor antagonist displaying broad-based antidepressant and anxiolytic properties in rodent models.

+ cite this

+ View Abstract

Dekeyne A, Mannoury la Cour C, Gobert A, Brocco M, Lejeune F, Serres F, Sharp T, Daszuta A, Soumier A, Papp M, Rivet JM, Flik G, Cremers TI, Muller O, Lavielle G, and Millan MJ

Psychopharmacology 199(4):549-68, 2008 Sep - Who cited this? | PubMed ID: 18523738 | Fulltext

Actions of novel agonists, antagonists and antipsychotic agents at recombinant rat 5-HT(6) receptors: A comparative study of coupling to Galphas.

+ cite this

+ View Abstract

Dupuis DS, la Cour CM, Chaput C, Verrièle L, Lavielle G, and Millan MJ

European journal of pharmacology 588(2-3):170, 2008 Jul 7 - Who cited this? | PubMed ID: 18511034 | Fulltext

S33138 [N-[4-[2-[(3aS,9bR)-8-cyano-1,3a,4,9b-tetrahydro[1]-benzopyrano[3,4-c]pyrrol-2(3H)-yl)-ethyl]phenylacetamide], a preferential dopamine D3 versus D2 receptor antagonist and potential antipsychotic agent: I. Receptor-binding profile and functional ac.

+ cite this

+ View Abstract

Millan MJ, Mannoury la Cour C, Novi F, Maggio R, Audinot V, Newman-Tancredi A, Cussac D, Pasteau V, Boutin JA, Dubuffet T, and Lavielle G

The Journal of pharmacology and experimental therapeutics 324(2):587, 2008 Feb - Who cited this? | PubMed ID: 18024789 | Fulltext

Novel E-ring camptothecin keto analogues (S38809 and S39625) are stable, potent, and selective topoisomerase I inhibitors without being substrates of drug efflux transporters.

+ cite this

+ View Abstract

Takagi K, Dexheimer TS, Redon C, Sordet O, Agama K, Lavielle G, Pierré A, Bates SE, and Pommier Y

Molecular cancer therapeutics 6(12 Pt 1):3229, 2007 Dec - Who cited this? | PubMed ID: 18089716 | Fulltext

Novel stable camptothecin derivatives replacing the E-ring lactone by a ketone function are potent inhibitors of topoisomerase I and promising antitumor drugs.

+ cite this

+ View Abstract

Lansiaux A, Léonce S, Kraus-Berthier L, Bal-Mahieu C, Mazinghien R, Didier S, David-Cordonnier MH, Hautefaye P, Lavielle G, Bailly C, Hickman JA, and Pierré A

Molecular pharmacology 72(2):311-9, 2007 Aug - Who cited this? | PubMed ID: 17494837 | Fulltext

The thromboxane receptor antagonist S18886 attenuates renal oxidant stress and proteinuria in diabetic apolipoprotein E-deficient mice.

+ cite this

+ View Abstract

Xu S, Jiang B, Maitland KA, Bayat H, Gu J, Nadler JL, Corda S, Lavielle G, Verbeuren TJ, Zuccollo A, and Cohen RA

Diabetes 55(1):110-9, 2006 Jan - Who cited this? | PubMed ID: 16380483 | Fulltext

The thromboxane A2 receptor antagonist S18886 prevents enhanced atherogenesis caused by diabetes mellitus.

+ cite this

+ View Abstract

Zuccollo A, Shi C, Mastroianni R, Maitland-Toolan KA, Weisbrod RM, Zang M, Xu S, Jiang B, Oliver-Krasinski JM, Cayatte AJ, Corda S, Lavielle G, Verbeuren TJ, and Cohen RA

Circulation 112(19):3001, 2005 Nov 8 - Who cited this? | PubMed ID: 16260636 | Fulltext

Synthesis and pharmacological evaluation of novel non-lactone analogues of camptothecin.

+ cite this

+ View Abstract

Hautefaye P, Cimetière B, Pierré A, Léonce S, Hickman J, Laine W, Bailly C, and Lavielle G

Bioorganic & medicinal chemistry letters 13(16):2731-5, 2003 Aug 18 - Who cited this? | PubMed ID: 12873503 | Fulltext

S 14506: novel receptor coupling at 5-HT(1A) receptors.

+ cite this

+ View Abstract

Milligan G, Kellett E, Dacquet C, Dubreuil V, Jacoby E, Millan MJ, Lavielle G, and Spedding M

Neuropharmacology 40(3):334-44, 2001 Mar - Who cited this? | PubMed ID: 11166326 | Fulltext

The thromboxane receptor antagonist S18886 but not aspirin inhibits atherogenesis in apo E-deficient mice: evidence that eicosanoids other than thromboxane contribute to atherosclerosis.

+ cite this

+ View Abstract

Cayatte AJ, Du Y, Oliver-Krasinski J, Lavielle G, Verbeuren TJ, and Cohen RA

Arteriosclerosis, thrombosis, and vascular biology 20(7):1724-8, 2000 Jul - Who cited this? | PubMed ID: 10894809 | Fulltext

S33084, a novel, potent, selective, and competitive antagonist at dopamine D(3)-receptors: I. Receptorial, electrophysiological and neurochemical profile compared with GR218,231 and L741,626.

+ cite this

+ View Abstract

Millan MJ, Gobert A, Newman-Tancredi A, Lejeune F, Cussac D, Rivet JM, Audinot V, Dubuffet T, and Lavielle G

The Journal of pharmacology and experimental therapeutics 293(3):1048-62, 2000 Jun - Who cited this? | PubMed ID: 10869410 | Fulltext

S33084, a novel, potent, selective, and competitive antagonist at dopamine D(3)-receptors: II. Functional and behavioral profile compared with GR218,231 and L741,626.

+ cite this

+ View Abstract

Millan MJ, Dekeyne A, Rivet JM, Dubuffet T, Lavielle G, and Brocco M

The Journal of pharmacology and experimental therapeutics 293(3):1063-73, 2000 Jun - Who cited this? | PubMed ID: 10869411 | Fulltext

Novel benzopyrano[3,4-c]pyrrole derivatives as potent and selective dopamine D3 receptor antagonist.

+ cite this

+ View Abstract

Dubuffet T, Newman-Tancredi A, Cussac D, Audinot V, Loutz A, Millan MJ, and Lavielle G

Bioorganic & medicinal chemistry letters 9(14):2059-64, 1999 Jul 19 - Who cited this? | PubMed ID: 10450981 | Fulltext

S 16924 ((R)-2-[1-[2-(2,3-dihydro-benzo[1,4] dioxin-5-Yloxy)-ethyl]-pyrrolidin-3yl]-1-(4-fluoro-phenyl)-ethanone), a novel, potential antipsychotic with marked serotonin (5-HT)1A agonist properties: I. Receptorial and neurochemical profile in comparison with clozapine and haloperidol.

+ cite this

+ View Abstract

Millan MJ, Gobert A, Newman-Tancredi A, Audinot V, Lejeune F, Rivet JM, Cussac D, Nicolas JP, Muller O, and Lavielle G

The Journal of pharmacology and experimental therapeutics 286(3):1341-55, 1998 Sep - Who cited this? | PubMed ID: 9732398 | Fulltext

S 16924 ((R)-2-[1-[2-(2,3-dihydro-benzo[1,4] dioxin-5-yloxy)-ethyl]-pyrrolidin-3yl]-1-(4-fluoro-phenyl)-ethanone), a novel, potential antipsychotic with marked serotonin (5-HT)1A agonist properties: II. Functional profile in comparison to clozapine and haloperidol.

+ cite this

+ View Abstract

Millan MJ, Schreiber R, Dekeyne A, Rivet JM, Bervoets K, Mavridis M, Sebban C, Maurel-Remy S, Newman-Tancredi A, Spedding M, Muller O, Lavielle G, and Brocco M

The Journal of pharmacology and experimental therapeutics 286(3):1356-73, 1998 Sep - Who cited this? | PubMed ID: 9732399 | Fulltext

Synthesis and biological evaluation of new tetrahydronaphthalene derivatives as thromboxane receptor antagonists.

+ cite this

+ View Abstract

Cimetière B, Dubuffet T, Muller O, Descombes JJ, Simonet S, Laubie M, Verbeuren TJ, and Lavielle G

Bioorganic & medicinal chemistry letters 8(11):1375-80, 1998 Jun 2 - Who cited this? | PubMed ID: 9871769 | Fulltext

New tetrahydronaphthalene derivatives as combined thromboxane receptor antagonists and thromboxane synthase inhibitors.

+ cite this

+ View Abstract

Cimetière B, Dubuffet T, Landras C, Descombes JJ, Simonet S, Verbeuren TJ, and Lavielle G

Bioorganic & medicinal chemistry letters 8(11):1381-6, 1998 Jun 2 - Who cited this? | PubMed ID: 9871770 | Fulltext

Activation of thromboxane receptors and the induction of vasomotion in the hamster cheek pouch microcirculation.

+ cite this

+ View Abstract

Verbeuren TJ, Vallez MO, Lavielle G, and Bouskela E

British journal of pharmacology 122(5):859-66, 1997 Nov - Who cited this? | PubMed ID: 9384501 | Fulltext

Agonist activity of antimigraine drugs at recombinant human 5-HT1A receptors: potential implications for prophylactic and acute therapy.

+ cite this

+ View Abstract

Newman-Tancredi A, Conte C, Chaput C, Verrièle L, Audinot-Bouchez V, Lochon S, Lavielle G, and Millan MJ

Naunyn-Schmiedeberg's archives of pharmacology 355(6):682-8, 1997 Jun - Who cited this? | PubMed ID: 9205951 | Fulltext

Binding profile of the novel 5-HT1B/1D receptor antagonist, [3H]GR 125,743, in guinea-pig brain: a comparison with [3H]5-carboxamidotryptamine.

+ cite this

+ View Abstract

Audinot V, Lochon S, Newman-Tancredi A, Lavielle G, and Millan MJ

European journal of pharmacology 327(2-3):247-56, 1997 May 30 - Who cited this? | PubMed ID: 9200567 | Fulltext

5-HT2C receptors mediate penile erections in rats: actions of novel and selective agonists and antagonists.

+ cite this

+ View Abstract

Millan MJ, Peglion JL, Lavielle G, and Perrin-Monneyron S

European journal of pharmacology 325(1):9-12, 1997 Apr 23 - Who cited this? | PubMed ID: 9151932 | Fulltext

S 18886, a new thromboxane (TP)-receptor antagonist is the active isomer of S 18204 in all species, except in the guinea-pig.

+ cite this

Simonet S, Descombes JJ, Vallez MO, Dubuffet T, Lavielle G, and Verbeuren TJ

Advances in experimental medicine and biology 433:173-6, 1997 - Who cited this? | PubMed ID: 9561128 | Fulltext

Relationship between the cellular accumulation and the cytotoxicity of S12363, a new Vinca alkaloid derivative.

+ cite this

+ View Abstract

Pierré A, Pérez V, Léonce S, Boutin JA, Saint-Dizier D, Hautefaye P, Lavielle G, and Atassi G

Cancer chemotherapy and pharmacology 29(5):367-74, 1992 - Who cited this? | PubMed ID: 1551175 | Fulltext

S 14671: a novel naphthylpiperazine 5-HT1A agonist of high efficacy and exceptional in vivo potency.

+ cite this

+ View Abstract

Millan MJ, Canton H, Rivet JM, Lejeune F, Laubie M, and Lavielle G

European journal of pharmacology 203(2):319-22, 1991 Oct 15 - Who cited this? | PubMed ID: 1839284 | Fulltext

New alpha-amino phosphonic acid derivatives of vinblastine: chemistry and antitumor activity.

+ cite this

+ View Abstract

Lavielle G, Hautefaye P, Schaeffer C, Boutin JA, Cudennec CA, and Pierré A

Journal of medicinal chemistry 34(7):1998-2003, 1991 Jul - Who cited this? | PubMed ID: 2066973 | Fulltext

Preclinical antitumor activity of a new Vinca alkaloid derivative, S 12363.

+ cite this

+ View Abstract

Pierré A, Kraus-Berthier L, Atassi G, Cros S, Poupon MF, Lavielle G, Berlion M, and Bizzari JP

Cancer research 51(9):2312-8, 1991 May 1 - Who cited this? | PubMed ID: 2015595 | Fulltext

Pharmacological properties of a new alpha-aminophosphonic acid derivative of vinblastine.

+ cite this

+ View Abstract

Pierré A, Lavielle G, Hautefaye P, Seurre G, Leonce S, Saint-Dizier D, Boutin JA, and Cudennec CA

Anticancer research 10(1):139-44, 1990 - Who cited this? | PubMed ID: 2334119 | Fulltext

Effects of the new nitrosourea derivative, fotemustine, on the glutathione reductase activity in rat tissues in vivo and in isolated rat hepatocytes.

+ cite this

+ View Abstract

Boutin JA, Norbeck K, Moldeus P, Genton A, Paraire M, Bizzari JP, Lavielle G, and Cudennec CA

European journal of cancer & clinical oncology 25(9):1311-6, 1989 Sep - Who cited this? | PubMed ID: 2806354 | Fulltext

Synthesis and psychoanaleptic properties of new compounds structurally related to diphenhydramine.

+ cite this

+ View Abstract

Buzas A, Champagnac A, Dehnel A, Lavielle G, and Pommier M

Journal of medicinal chemistry 23(2):149-53, 1980 Feb - Who cited this? | PubMed ID: 6102153 | Fulltext

[Synthesis and amoebicid properties of emetin analogs. Analysis of the new compounds by 13C-NMR. B/C-cis or trans-fused (+/-) 1-alkyl-3-desethyl-emetin (author's transl)].

+ cite this

Buzas A, Cavier R, Cossais F, Finet JP, Jacquet JP, Lavielle G, and Platzer N

Helvetica chimica acta 60(7):2122-34, 1977 Nov 2 - Who cited this? | PubMed ID: 200588 | Fulltext

Search Google Scholar for Lavielle G

Join Labmeeting

Organize and search your PDF collection
Collect papers
Search millions of papers
Keep up to date with paper alerts
Read your papers from anywhere
Recommend papers to colleagues
Manage your lab

Labmeeting is a web service for researchers. Sign up with your academic email address.

Individuals or corporations not affiliated with an academic institution can request a trial subscription.

Got a question?
The Labmeeting Network
has the answer.
Ask scientists at top universities like Harvard, Stanford, and MIT for their expert opinion!